Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Singapore Institute Of Advanced Medicine HoldingsSGX:9G2 +3.45% Forward Dividend Yield % is 0.00% as of Aug. 19, 2026. The stock has 2 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Singapore Institute Of Advanced Medicine Holdings ranks worse than 354609.57% on this metric.
SGX:9G2's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.43 * Ranked among companies with meaningful Forward Dividend Yield % only.
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Singapore Institute Of Advanced Medicine Holdings Forward Dividend Yield % Related Terms
SGX:9G2 vs HCA, THC, DVA: Forward Dividend Yield % Comparison
For the Medical Care Facilities subindustry, Singapore Institute Of Advanced Medicine Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singapore Institute Of Advanced Medicine Holdings Forward Dividend Yield % vs Healthcare Providers & Services Industry
What does a Forward Dividend Yield % of 0.00% mean?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a Forward Dividend Yield % of 0.00% as of Aug. 19, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. According to the industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 282 companies in the Healthcare Providers & Services industry.
Is Singapore Institute Of Advanced Medicine Holdings' Forward Dividend Yield % too high?
Singapore Institute Of Advanced Medicine Holdings' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 282 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Singapore Institute Of Advanced Medicine Holdings' Forward Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Singapore Institute Of Advanced Medicine Holdings ranks #999999 out of 282 companies for Forward Dividend Yield %. This places Singapore Institute Of Advanced Medicine Holdings in the lower half of its industry. The industry median Forward Dividend Yield % is 2.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.43, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Singapore Institute Of Advanced Medicine Holdings and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Singapore Institute Of Advanced Medicine Holdings's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singapore Institute Of Advanced Medicine Holdings stock overvalued right now?
Singapore Institute Of Advanced Medicine Holdings (SGX:9G2) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Singapore Institute Of Advanced Medicine Holdings (SGX:9G2), the current Forward Dividend Yield % is 0.00% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Singapore Institute of Advanced Medicine Holdings Ltd is a Singapore-based healthcare service provider comprising a medical center, diagnostic imaging facility, nuclear medicine clinic, and radiation oncology service providing proton and X-ray radiotherapy. Its operating segments are: Medical Diagnostics and Treatments, Radiation Therapy and Medical Oncology Services, and Investment Holding. Medical Diagnostics and Treatments include: cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services. Radiation Therapy encompasses proton beam therapy, photon radiation therapy, and Medical oncology. The majority of the company's revenue comes from the Medical Diagnostics and Treatments segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:9G2 has been successfully added to your 
